Headaches in the pediatric population

Paula M Brna1, Joseph M Dooley

  • 1Department of Pediatrics, Division of Pediatric Neurology, IWK Health Centre, Halifax, Nova Scotia, Canada.

Insights

Pediatric headaches are common, with history and examination crucial for diagnosis and identifying serious causes. Management prioritizes non-pharmacologic approaches for lifelong prevention and improved quality of life.

Area of Science:

  • Pediatric Neurology
  • Headache Medicine

Background:

  • Headaches are a frequent neurological complaint in children.
  • Accurate diagnosis is essential for appropriate management and to rule out secondary causes.

Purpose of the Study:

  • To outline a systematic approach for diagnosing and managing pediatric headaches.
  • To emphasize the importance of headache history and examination in identifying serious underlying conditions.
  • To review current evidence for pharmacologic and non-pharmacologic treatment strategies.

Main Methods:

  • Review of clinical guidelines and existing literature on pediatric headaches.
  • Emphasis on diagnostic criteria derived from patient history and neurological examination.
  • Discussion of therapeutic strategies including non-pharmacologic and pharmacologic interventions.

Main Results:

  • Headache history is paramount in establishing diagnosis and screening for secondary causes.
  • Neurological examination is key to excluding serious organic causes.
  • Non-pharmacologic interventions form the cornerstone of lifelong headache management and prevention.

Conclusions:

  • A thorough headache history and examination are critical for pediatric headache diagnosis and management.
  • Non-pharmacologic approaches should be the primary strategy, focusing on education and lifestyle.
  • Further research is needed to optimize prophylactic treatments for significant pediatric headache disability.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Increased Intracranial Pressure l: Introduction01:14

Increased Intracranial Pressure l: Introduction

Intracranial hypertension is a sustained elevation of intracranial pressure (ICP) above 22 mm Hg. In supine adults, normal ICP is ~7–15 mm Hg.The rigid, nonexpandable cranium contains three components—brain tissue, blood, and cerebrospinal fluid (CSF)—that total ~1,700 mL in a typical adult: 1,400 mL brain (~80%), 150 mL blood (~10%), and 150 mL CSF (~10%). According to the Monro–Kellie doctrine, total intracranial volume is effectively fixed. When one component expands, CSF and venous blood...